People: Becton Dickinson and Co (BDX)
21 Sep 2017
Mr. Vincent A. Forlenza is Chairman of the Board, Chief Executive Officer of Becton, Dickinson and Company. During his more than 35-year career with BD, Mr. Forlenza has held a number of executive leadership positions globally, in the United States and in Europe. Mr. Forlenza was named President in January 2009, assumed additional responsibility as Chief Operating Officer in July 2010, and became Chief Executive Officer in October 2011 and Chairman of the Board in July 2012. Previous appointments include leadership roles as Senior Vice President, Technology, Strategy and Development; President of BD Biosciences; and Executive Vice President and President, BD Diagnostics. Mr. Forlenza is the former Chairman of the Advanced Medical Technology Association (AdvaMed) Board of Directors. As chairman, he significantly advanced the association’s innovation agenda, collaborating with policymakers and industry partners to reinvigorate the innovation ecosystem and promote the value of medical technology in extending and improving patients’ lives, enhancing population health and supporting economically sound health systems. He served on both the AdvaMed Board and its Executive Committee for seven years and is also the past chair of the association’s Board Committee on Technology and Regulation. In addition, he served as Chairman of the Board for AdvaMedDx, a division of AdvaMed focused on the unique needs and issues facing diagnostics manufacturers. Mr. Forlenza currently serves on the Board of Trustees at The Valley Health Systems and previously served as Chairman of The Valley Hospital. He is a past member of the Advisory Board for the P.C. Rossin College of Engineering and Applied Sciences at Lehigh University, where he also served as a member of the Board of Trustees. Mr. Forlenza obtained his bachelor’s degree in chemical engineering from Lehigh University in 1975 and his MBA from Wharton Graduate School, University of Pennsylvania in 1980.
|Total Annual Compensation, USD||3,105,000|
|Restricted Stock Awards, USD||10,294,700|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||530,762|
|Fiscal Year Total, USD||13,930,500|